Laboratory Corporation of America Holdings Stock Price and Value Analysis

Laboratory Corporation of America Holdings (NYSE:LH) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: LH (NYSE)
  • Current price: $370.78
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield: 0.78%

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Laboratory Corporation of America Holdings to reach your target.

Target type

LH Free Cash Flow Trend

Free Cash Flow trendline for LH
Free Cash Flow trendline for Laboratory Corporation of America Holdings
CSV

Based on historical returns, we believe that Laboratory Corporation of America Holdings can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This company is very stable.
  • This company has a low dividend yield.
  • This company has wild ups and downs.
  • This stock looks fairly priced.

Inside the LH Numbers

LH Price
(Laboratory Corporation of America Holdings stock price per share)
$370.78
[?] LH Fair Price
(based on intrinsic value)
$381.25
[?] LH Safety Price (based on a variable margin of safety) $305.00
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 61% lower than other Unknown stocks
[?] PE Ratio versus Industry 93% lower than other Unknown stocks
[?] Cash Yield 3.93%
[?] Free Cash Flow Jitter 39%
[?] Dividend Yield 0.78% (tax impact)
Shares Shorted 2,544,414

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,544,414 shares shorted. With 80,819,984 shares available for purchase and an average trading volume over the past 10 trading days of 647,770, it would take at least 3.9 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2007 920148 567.1
2008 920148 631.2
2009 920148 724.4
2010 920148 748.6
2011 920148 718.4
2012 920148 698.0
2013 920148 666.2
2014 920148 568.7
2015 920148 786.2
2016 920148 974.3
2017 920148 1247.4
2018 920148 1019.2
2019 920148 1119.2
2020 920148 1784.6
2021 920148 2730.4
2022 920148 1553.4
2023 920148 910.4
2024 920148 1150.6
2025 920148 1194.7

Download the yearly data as CSV.

Cash Conversion

Over the 19 fiscal years from 2007 to 2025 with positive net income, operating cash flow totaled $24673.8 million against net income of $15567.6 million, or 1.58 times.

In 2025, operating cash flow was 1.87 times net income, compared with 1.58 times for the earliest three years (2007 to 2009).

In 2025, capital expenditures were $434.5 million, 26.5% of operating cash flow of $1640.5 million, which leaves an estimated $1206.0 million after capex. Across the 19 years with reported capex, it averaged 22.3% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2007 476.8 709.7 142.6 1.49
2008 464.5 780.9 156.7 1.68
2009 543.3 862.4 114.7 1.59
2010 558.2 883.6 126.1 1.58
2011 519.7 855.6 145.7 1.65
2012 583.1 841.4 173.8 1.44
2013 573.8 818.7 202.2 1.43
2014 511.2 739.0 203.5 1.45
2015 437.6 982.4 255.8 2.24
2016 711.8 1197.1 278.9 1.68
2017 1227.1 1498.1 312.9 1.22
2018 883.7 1305.4 379.8 1.48
2019 823.8 1444.7 400.2 1.75
2020 1556.1 2135.3 381.7 1.37
2021 2377.3 3109.6 421.5 1.31
2022 1279.1 1955.9 429.3 1.53
2023 418.0 1327.7 453.6 3.18
2024 746.0 1585.8 489.9 2.13
2025 876.5 1640.5 434.5 1.87

Revenue and Cash Margin

Revenue was $4068.2 million in 2007 and $13951.7 million in 2025, a compound annual growth rate of 7.1% over 18 years.

Revenue rose 7.2% from 2024 to 2025.

Our estimated free cash flow was $1194.7 million in 2025, 8.6% of revenue. In 2007 the estimated margin was 13.9%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2007 4068.2 567.1 13.9%
2008 4505.2 631.2 14.0%
2009 4694.7 724.4 15.4%
2010 5003.9 748.6 15.0%
2011 5542.3 718.4 13.0%
2012 5671.4 698.0 12.3%
2013 5808.3 666.2 11.5%
2014 6011.6 568.7 9.5%
2015 8680.1 786.2 9.1%
2016 9552.9 974.3 10.2%
2017 10308.0 1247.4 12.1%
2018 11333.4 1019.2 9.0%
2019 11554.8 1119.2 9.7%
2020 13978.5 1784.6 12.8%
2021 13136.1 2730.4 20.8%
2022 11863.9 1553.4 13.1%
2023 12161.6 910.4 7.5%
2024 13008.9 1150.6 8.8%
2025 13951.7 1194.7 8.6%

Balance Sheet

In 2025, cash and equivalents were $532.3 million against total liabilities of $9772.9 million, or 5.4% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 53.1% of total assets in 2025, compared with 61.2% in 2008, a decrease of 8.1 percentage points.

Stockholders equity was $8619.8 million in 2025, compared with $1809.6 million in 2008, a rise of 376.3%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 7.9% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2008 4669.5 219.7 2859.9 1809.6
2009 4837.8 148.5 2731.7 2106.1
2010 6187.8 159.3 3721.5 2466.3
2011 6111.8 159.3 3608.3 2503.5
2012 6795.0 404.0 1849.9 4945.1
2013 6965.9 404.0 4474.6 2491.3
2014 7301.8 580.0 4481.3 2820.5
2015 14104.7 716.4 9159.6 4945.1
2016 14247.0 433.6 8728.8 5518.2
2017 16673.0 316.6 9868.9 6804.1
2018 16185.3 426.8 9137.0 7048.3
2019 18046.4 337.5 10402.5 7643.9
2020 20071.7 1320.8 10635.1 9436.6
2021 20385.4 1472.7 10112.0 10273.4
2022 20155.1 320.6 10058.5 10096.6
2023 16725.1 536.8 8850.1 7875.0
2024 18379.0 1518.7 10326.8 8052.2
2025 18392.7 532.3 9772.9 8619.8

Price Versus Our Estimated Value

Free cash flow was positive in all 19 fiscal years we have for Laboratory Corporation of America Holdings under its current SEC filer.

The latest three years average $1085.3 million in free cash flow against $640.9 million for the earliest three, which is a sharp rise.

Year-to-year variability in free cash flow is volatile, measured at 39%.

Laboratory Corporation of America Holdings at $370.78 lies between its safe value ($305.00) and its fair value ($381.25).

Laboratory Corporation of America Holdings pays a dividend yield of 0.78%.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 920148.

Each figure on this page comes from that filer.

Risks to This Analysis

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in LH

Does Laboratory Corporation of America Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: LH

This example shows how we apply the Trendshare checklist to LH: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 370.78
    • Market cap: $30B
    • EPS: 12.2
  2. Step 2 — Valuation checks

    • P/E: 30.392
    • FCF yield: 3.9%
    • Date checked: Nov 18, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.